248 related articles for article (PubMed ID: 28377419)
1. Thyroid-Stimulating Hormone, Thyroid Hormones, and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study.
Huang H; Rusiecki J; Zhao N; Chen Y; Ma S; Yu H; Ward MH; Udelsman R; Zhang Y
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1209-1218. PubMed ID: 28377419
[No Abstract] [Full Text] [Related]
2. Preoperative thyroid-stimulating hormone associated risk of differentiated thyroid cancer in patients with thyroid nodules.
M AE
Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):85-91. PubMed ID: 34933729
[TBL] [Abstract][Full Text] [Related]
3. Fasting serum glucose, thyroid-stimulating hormone, and thyroid hormones and risk of papillary thyroid cancer: A case-control study.
Hu MJ; Zhang C; Liang L; Wang SY; Zheng XC; Zhang Q; Jiang CX; Zhong Q; Huang F
Head Neck; 2019 Jul; 41(7):2277-2284. PubMed ID: 30759328
[TBL] [Abstract][Full Text] [Related]
4. Inverse Relationship of BMI to TSH and Risk of Papillary Thyroid Cancer in Surgical Patients.
Handelsman RS; Alvarez AL; Picado O; Farrá JC; Lew JI
J Surg Res; 2019 Dec; 244():96-101. PubMed ID: 31280000
[TBL] [Abstract][Full Text] [Related]
5. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients.
Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Miccoli P; Grasso L; Pinchera A; Vitti P
Endocr Relat Cancer; 2010 Mar; 17(1):231-9. PubMed ID: 20167722
[TBL] [Abstract][Full Text] [Related]
6. Organochlorine pesticides and risk of papillary thyroid cancer in U.S. military personnel: a nested case-control study.
Rusiecki JA; McAdam J; Denic-Roberts H; Sjodin A; Davis M; Jones R; Hoang TD; Ward MH; Ma S; Zhang Y
Environ Health; 2024 Mar; 23(1):28. PubMed ID: 38504322
[TBL] [Abstract][Full Text] [Related]
7. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
[TBL] [Abstract][Full Text] [Related]
8. Polybrominated Diphenyl Ethers, Polybrominated Biphenyls, and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study.
Huang H; Sjodin A; Chen Y; Ni X; Ma S; Yu H; Ward MH; Udelsman R; Rusiecki J; Zhang Y
Am J Epidemiol; 2020 Feb; 189(2):120-132. PubMed ID: 31742588
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas.
Sohn SY; Kim HJ; Jang HW; Kim SW; Chung JH
Head Neck; 2014 Jan; 36(1):43-6. PubMed ID: 23728859
[TBL] [Abstract][Full Text] [Related]
10. Hashimoto's thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?
Divani SN; Kalodimos GP; Lioupis MA; Syrmos NC
Hell J Nucl Med; 2016; 19(3):250-253. PubMed ID: 27824965
[TBL] [Abstract][Full Text] [Related]
11. Relationship between preoperative serum TSH levels and expression of VEGF in papillary thyroid carcinoma.
Li J; Teng L; Jiang H
Asia Pac J Clin Oncol; 2014 Jun; 10(2):149-52. PubMed ID: 23718885
[TBL] [Abstract][Full Text] [Related]
12. Oncofetal fibronectin mRNA is highly abundant in the blood of patients with papillary thyroid carcinoma and correlates with high-serum thyroid-stimulating hormone levels.
Wehmeier M; Petrich T; Brand K; Lichtinghagen R; Hesse E
Thyroid; 2010 Jun; 20(6):607-13. PubMed ID: 20470202
[TBL] [Abstract][Full Text] [Related]
13. Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer.
Tam AA; Ozdemir D; Aydın C; Bestepe N; Ulusoy S; Sungu N; Ersoy R; Cakir B
Endocrine; 2018 Mar; 59(3):565-572. PubMed ID: 29374347
[TBL] [Abstract][Full Text] [Related]
14. 25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma.
Danilovic DL; Ferraz-de-Souza B; Fabri AW; Santana NO; Kulcsar MA; Cernea CR; Marui S; Hoff AO
PLoS One; 2016; 11(10):e0164550. PubMed ID: 27737011
[TBL] [Abstract][Full Text] [Related]
15. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis.
Kim KW; Park YJ; Kim EH; Park SY; Park DJ; Ahn SH; Park DJ; Jang HC; Cho BY
Head Neck; 2011 May; 33(5):691-5. PubMed ID: 21484918
[TBL] [Abstract][Full Text] [Related]
16. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
Xia Q; Dong S; Bian PD; Wang J; Li CJ
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1037-43. PubMed ID: 25744048
[TBL] [Abstract][Full Text] [Related]
17. RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease.
Su X; He C; Ma J; Tang T; Zhang X; Ye Z; Long Y; Shao Q; Shao J; Yang A
PLoS One; 2016; 11(11):e0165596. PubMed ID: 27802347
[TBL] [Abstract][Full Text] [Related]
18. [Value of VEGF-C, VEGF-D and VEGFR-3 levels combined with serum TSH in diagnosis of papillary thyroid carcinoma].
Huang J; Li Y; Xue G; Zhang W; Li S; Zhang J; Wu J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1814-7, 1821. PubMed ID: 25537909
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of 25(OH)D3, concentration levels in patients with papillary thyroid cancer compared to patients with Hashimoto's thyroiditis].
Lizis-Kolus K; Hubalewska-Dydejczyk A; Trofimiuk-Muldnerz M; Sowa-Staszczak A; Kowalska A
Przegl Lek; 2013; 70(11):920-5. PubMed ID: 24697030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
